research use only
Cat.No.S7732
| Related Targets | PD-1/PD-L1 CXCR STING AhR Immunology & Inflammation related CD markers Interleukins Anti-infection Antioxidant COX |
|---|---|
| Other MIF Inhibitors | 4-IPP BTZO-1 Chicago Sky Blue 6B |
|
In vitro |
DMSO
: 47 mg/mL
(199.79 mM)
Ethanol : 47 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 235.24 | Formula | C12H13NO4 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 478336-92-4 | -- | Storage of Stock Solutions |
|
|
| Synonyms | MIF Antagonist | Smiles | COC(=O)CC1CC(=NO1)C2=CC=C(C=C2)O | ||
| Targets/IC50/Ki |
MIF
7 μM
|
|---|---|
| In vitro |
ISO-1 significantly inhibits the cytokine activity in vitro. It inhibits tumor necrosis factor release from macrophages isolated from LPStreated wild type mice but has no effect on cytokine release from MIF-deficient macrophages. |
| In vivo |
ISO-1 significantly increases the survival rate in severe sepsis induced by endotoxin or cecal ligation and puncture (CLP). It could prevent airway hyperresponsiveness (AHR) in mouse ovalbumin (OVA)-challenge models. This compound attenuated ozone-induced cell recruitment, cytokine release and AHR in the mouse but did not affect measures of emphysema. It protects photoreceptors and reduces gliosis in experimental retinal detachment. |
References |
|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT02284919 | Active not recruiting | Breast Cancer|Breast Neoplasm |
University of Pennsylvania |
November 2014 | Phase 1 |
| NCT02204202 | Terminated | Lung Disease |
Washington University School of Medicine|National Heart Lung and Blood Institute (NHLBI) |
February 2014 | -- |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.